baohuoside-i has been researched along with Acute-Disease* in 1 studies
1 other study(ies) available for baohuoside-i and Acute-Disease
| Article | Year |
|---|---|
Effect of Baohuoside-1 aglycone and tacrolimus monotherapy and combination therapy on prevention of acute heart allograft rejection in the rat.
Baohuoside-1 (B-1), a recently introduced novel immunosuppressant that was proved to be potent in inhibition of T and B cell proliferation and B-1, also prevents cardiac allograft rejection in rodents. The present study further proved that monotherapy of B-1's analogue B-1 aglycone effectively prolongs cardiac allograft survival and combination therapy of B-1 aglycone with tacrolimus (FK506) produces synergistic effect in prevention acute cardiac allograft rejection in the rat. . Topics: Acute Disease; Animals; Drug Therapy, Combination; Flavonoids; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Random Allocation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Survival Rate; Tacrolimus; Transplantation, Homologous | 2007 |